FGF2 and neoplasm: PMN-MDSCs can also facilitate tumor angiogenesis by releasing proangiogenic cytokines like basic fibroblast growth factor (bFGF) and VEGF, facilitate metastasis of tumor by releasing matrix metalloproteinases, and contribute to the progression of epithelial-to-mesenchymal transition (EMT) [472].